Demoly P, Jaffuel D, Mathieu M, Sahla H, Godard P, Michel F B, Bousquet J
INSERM U454, Hôpital Arnaud de Villeneuve, CHU de Montpellier, France.
Thorax. 1998 Dec;53(12):1063-5. doi: 10.1136/thx.53.12.1063.
Glucocorticoid resistant or insensitive asthmatic subjects are usually defined as patients whose baseline pre-bronchodilation forced expiratory volume in one second (FEV1) of less than 70-80% predicted improves significantly in response to beta 2 agonists but by less than 15% following 1-2 weeks of 40 mg prednisolone daily. Since there is little long term clinical information on these patients, a one year prospective study was performed to assess whether glucocorticoid sensitivity may vary over time.
Nineteen severe asthmatic subjects were studied and received 40 mg prednisolone daily for seven days. Prednisolone was given for a further seven days in glucocorticoid insensitive asthmatics and then stopped. Patients were followed up for one year and the glucocorticoid test was repeated on five patients in each group six months later.
Eleven patients were classified as glucocorticoid insensitive and eight as glucocorticoid sensitive on day 7. The demographic characteristics of the patients were similar in both groups. Four glucocorticoid insensitive patients became responsive after one further week of prednisolone treatment. Six months later, four of five glucocorticoid sensitive patients and three of five previously glucocorticoid insensitive patients were glucocorticoid sensitive.
Glucocorticoid sensitivity varies over time.
糖皮质激素抵抗或不敏感的哮喘患者通常被定义为那些基线支气管扩张前一秒用力呼气量(FEV1)低于预测值70%-80%的患者,其FEV1在β2激动剂作用下显著改善,但在每日40mg泼尼松龙治疗1-2周后改善幅度小于15%。由于关于这些患者的长期临床信息较少,因此进行了一项为期一年的前瞻性研究,以评估糖皮质激素敏感性是否会随时间变化。
对19名重度哮喘患者进行研究,他们每日接受40mg泼尼松龙治疗7天。对于糖皮质激素不敏感的哮喘患者,再给予7天泼尼松龙治疗后停药。对患者进行一年的随访,并在6个月后对每组中的5名患者重复进行糖皮质激素测试。
在第7天,11名患者被分类为糖皮质激素不敏感,8名患者被分类为糖皮质激素敏感。两组患者的人口统计学特征相似。4名糖皮质激素不敏感患者在进一步接受一周泼尼松龙治疗后变得敏感。6个月后,5名糖皮质激素敏感患者中的4名以及5名先前糖皮质激素不敏感患者中的3名对糖皮质激素敏感。
糖皮质激素敏感性随时间变化。